Related Experiment Video

Updated: Jun 21, 2026

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes

Magdalena Pasarica1, Yourka D Tchoukalova, Leonie K Heilbronn

  • 1Human Physiology, Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Obesity (Silver Spring, Md.)
|July 25, 2009
PubMed

Insights

Weight loss in type 2 diabetes patients reduced large fat cell size, improving insulin sensitivity and increasing adiponectin. This highlights the importance of adipocyte size distribution for metabolic health.

Area of Science:

  • Metabolic Health
  • Endocrinology
  • Diabetes Research

Background:

  • Adipocyte size influences function and responsiveness to interventions.
  • Understanding adipocyte dynamics is crucial for managing type 2 diabetes mellitus (T2DM).

Purpose of the Study:

  • To investigate if weight loss in T2DM patients primarily reduces large adipocyte size.
  • To correlate changes in adipocyte size with improvements in insulin sensitivity and serum adipokines.

Main Methods:

  • Analysis of 44 T2DM volunteers from the Look Action for Health in Diabetes trial.
  • Measurement of insulin sensitivity via hyperinsulinemic-euglycemic clamp.
  • Assessment of subcutaneous abdominal adipocyte size and serum adipokine levels.

Main Results:

  • 13% weight loss improved insulin sensitivity by 46% and increased adiponectin by 36%.
  • Mean adipocyte size decreased, primarily due to a reduction in large adipocyte subfractions.
  • Changes in adiponectin correlated with improved glucose disposal rate.

Conclusions:

  • Weight loss-induced improvements in insulin sensitivity in T2DM may be linked to reduced large adipocyte size and increased adiponectin.
  • Adipocyte size distribution, not just mean size, is important for understanding metabolic improvements.
  • Further studies should incorporate adipocyte size distribution and in vitro analyses.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...